Pediatric Allergy Care Global Market Report 2026

The pediatric allergy care market size has grown strongly in recent years. It will grow from $5.22 billion in 2025 to $5.64 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising prevalence of pediatric allergies, increasing awareness among parents, development of pediatric immunotherapy, adoption of traditional allergy testing methods, growth of specialty allergy clinics.

The pediatric allergy care market size is expected to see strong growth in the next few years. It will grow to $7.78 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of ai-driven diagnostics, personalized treatment plans using genomics, integration of digital health platforms, demand for remote monitoring solutions. Major trends in the forecast period include telehealth expansion, personalized allergy management, remote symptom monitoring, integration with pediatric care platforms, digital prescription management.

The rising incidence of food allergies among children is expected to propel the growth of the pediatric allergy care market in the coming years. Food allergies in children involve immune system reactions when a child’s body mistakenly identifies certain foods as harmful, triggering symptoms ranging from mild, such as hives or stomach upset, to severe, including anaphylaxis. The rising incidence is attributed to the hygiene hypothesis, which suggests that reduced early exposure to microbes results in an underdeveloped immune system that overreacts to harmless foods. Pediatric allergy care supports children with food allergies through early diagnosis, personalized management plans, and education to prevent allergic reactions and enhance overall quality of life. For instance, in January 2026, according to the Centers for Disease Control and Prevention, a US-based public health agency, the percentage of children diagnosed with a food allergy increased to 5.3% in 2024 from 3.5% in 2023. Therefore, the rising incidence of food allergies in children is driving the growth of the pediatric allergy care market.

Leading companies operating in the pediatric allergy care market are focusing on developing innovative solutions such as prescription oral immunotherapy (OIT) treatment to desensitize children to allergens and reduce the risk of severe allergic reactions. Prescription oral immunotherapy (OIT) is a medically supervised treatment that gradually exposes patients to small, increasing amounts of an allergen, such as peanuts, to build tolerance and reduce the risk of severe allergic reactions. For example, in February 2025, Stallergenes Greer International AG, a Switzerland-based biopharmaceutical company, launched Palforzia Oral Immunotherapy (OIT) in the U.S. for children aged 1 to 3 years, expanding its previous indication to include toddlers with confirmed peanut allergies. The therapy consists of defatted peanut allergen powder administered orally through a staged regimen of initial dose escalation, gradual up-dosing, and daily maintenance, designed to reduce allergic reactions, including anaphylaxis, after accidental peanut exposure. Unique aspects include age-specific dosing and use alongside a peanut-avoidant diet to build tolerance. This treatment addresses a critical unmet need in very young children by offering a proactive option beyond avoidance and emergency care, with the potential to modify the natural course of peanut allergy in early childhood.

In September 2025, Allied Allergy & Asthma, a US-based healthcare services company, acquired the Allergy, Asthma, and Sinus Center for an undisclosed amount. With this acquisition, Allied aims to improve access to specialized allergy, asthma, and sinus care across Long Island's eight new locations. The Allergy, Asthma, and Sinus Center is a US-based healthcare provider delivering comprehensive pediatric allergy, asthma, and immunology services for infants, children, and adolescents.

Major companies operating in the pediatric allergy care market are market are AstraZeneca PLC, Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics Incorporated, Medicover Woman & Child Hospital, Nemours Children's Health, EUROIMMUN Medizinische Labordiagnostika AG, ALK-Abelló A/S, Stallergenes Greer S.A., Rainbow Children's Hospital, Continental Hospitals, Viracor Eurofins, R-Biopharm AESKU.GROUP GmbH And Co. KG, Apollo Cradle And Children’s Hospital, Hycor Biomedical Inc., AESKU.GROUP GmbH, Ankura Hospital for Women And Children, Nectar Allergy And Asthma, Ann And Robert H. Lurie Children's Hospital of Chicago, DBV Technologies S.A.

North America was the largest region in the pediatric allergy care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric allergy care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric allergy care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pediatric allergy care market includes revenues earned by entities through prescription allergy medications, allergy testing services, immunotherapy treatments, consultation and clinical services, and nutritional and probiotic supplements. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pediatric allergy care is the specialized medical practice focused on diagnosing, managing, and treating allergies in children, including food, environmental, and drug-related sensitivities. It aims to improve a child’s quality of life by preventing allergic reactions, controlling symptoms, and providing education for long-term management.

The key care modalities of pediatric allergy care include drug therapy, allergy testing, pediatric immunotherapy, and telehealth and support. Drug therapy involves the use of medications to manage and treat allergic conditions in children, controlling symptoms and preventing complications. Condition types include asthma, food allergy, allergic rhinitis, eczema, and anaphylaxis. Applications cover pediatric asthma care, food allergy diagnostics, integrated management of allergic rhinitis and eczema, anaphylaxis prevention, and immunotherapy programs, serving specialty allergy clinics, hospitals, diagnostic laboratories, telehealth providers, and other end users.

Tariffs have affected the pediatric allergy care market by increasing the cost of importing specialized drugs, diagnostic tools, and immunotherapy equipment. Segments such as drug therapy and allergy testing are most impacted, particularly in regions like North America and Europe with high import dependency. However, tariffs are encouraging local manufacturing and innovation in cost-effective treatment solutions, supporting market diversification and resilience.

The pediatric allergy care market research report is one of a series of new reports that provides pediatric allergy care market statistics, including pediatric allergy care industry global market size, regional shares, competitors with a pediatric allergy care market share, detailed pediatric allergy care market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric allergy care industry. This pediatric allergy care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.